On Monday Pfizer Inc (PFE.N) said that it had dosed the first patient in a trial testing a flu vaccine based on messenger RNA, the same technology used in the COVID-19 shots made by the U.S. drugmaker and BioNTech . Conducted in the United States, the early-stage vaccine
WHO chief scientist Soumya Swaminathan has said, citing sero-survey results and huge learning loss over past 18 months that Tamil Nadu should consider reopening schools for all classes,. On Sunday in an event, Soumya said one of the main findings of ICMR’s fourth sero prevalence study conducted in June
According to a study published on Monday by Oxford University, the COVID-19 pandemic reduced life expectancy in 2020 by the largest amount since World War Two, with the life expectancy of American men dropping by more than two years. Life expectancy cut by more than six
The total number of the mosquito borne infection so far this year in Delhi has crossed the 200 mark, With 53 more cases of dengue recorded in the Capital over the last week. According to the weekly report released by the municipal corporations on Monday, Delhi recorded
On Saturday, States and Union Territories should undertake in-depth analysis of the COVID-19 situation and strengthen health infrastructure, stock essential medicines and augment human resources, Cabinet Secretary Rajiv Gauba said, stressing that there is no room for any complacency. Gauba chaired a high-level meeting through video conference
The U.S. Food and Drug Administration has declined Humanigen Inc's (HGEN.O) request for emergency use authorization (EUA) of its lenzilumab drug to treat newly hospitalized COVID-19 patients, as stated by the company on Thursday. "In its letter, FDA stated that it was unable to conclude that the known
Last year and a half was a big announcement that we need to improve the healthcare infrastructure globally. This pandemic presented us with many areas for innovation and better management, which lead to proactive government policies and participation of businesses and academia alike in R&D. Focusing
Truenat, an innovative point of care Real-Time PCR platform manufactured by Goa-based Molbio Diagnostics, has received Emergency Use Authorization by the DCGI for their Nipah test. This is the first kit in India to receive regulatory approval to conduct tests for Nipah. Nipah virus (NiV) is
Q1) Tell us a little bit about your journey in establishing yourself in the UAE. I started my journey back in 2015 after spending about a decade in healthcare in India. I remember that we had come to Dubai thinking we would relocate to the West in
Various organizations in the U.S. are working to invest $3 billion in the vaccine supply chain as the country continues to position itself as a leading supplier of vaccines for the world, a top U.S. health official said on Thursday. The funding, which will begin to
